Impact of gender on tumor stage and survival of upper urinary tract urothelial cancer
Tóm tắt
The aim of this study was to analyze the impact of gender on tumor stage, overall and cancer-specific mortality of upper urinary tract urothelial cancer (UTUC) in a population-based, nationwide analysis. All Austrian patients with UTUC diagnosed between 1983 and 2010 were included in this study. Overall mortality was estimated by the Kaplan-Meier method. Cancer-specific (UTUC) mortality was estimated by cumulative incidence with mortality due to other causes as a competing risk. The effect of age was adjusted in a descriptive as well as a statistical inferential way. This study included 2066 patients (men n = 1169, mean age 68.3 ±11.5 years, women n = 897, 72.6 ±10.4 years). Tumor stage distribution was as follows: pT1: men n = 411, women n = 268, pT2: men n = 263, women n = 187, pT3: men n = 382, women n = 328 and pT4: men n = 113, women n = 114. The male:female ratio continuously declined from 1.5 for pT1 tumors to 1.4 for pT2 tumors, 1.2 for pT3 tumors and 1.0 for pT4-tumors. In the entire cohort the 5‑year cumulative overall mortality was 57 % for women versus 50 % for men (p = 0.0002). For pT1 (women 33 %, men 31 %) and pT2 stage tumors (women 45 %, men 45 %) the 5‑year overall mortality was comparable between both sexes. In pT3 (women 68 %, men 62 %) and pT4 (women 95 %, men 87 %) tumors women had a higher overall mortality rate. The 5‑year cancer-specific mortality (CSM) of the entire cohort was 12 % for women and 10 % for men (p = 0.067): pT1 women 5 % men 3 %, pT2 women 9 % men 10 %, pT3 women 14 % men 11 % and pT4 women 29 % men 27 %. In this population-based nationwide analysis, sex differences were notable for UTUC. Women tended to have more advanced tumor stages at diagnosis and a higher overall and cancer-specific mortality in advanced tumor stages.
Tài liệu tham khảo
Roupret M, Babjuk M, Comperat E, et al. European guidelines on upper tract urothelial carcinomas. Eur Urol. 2013;63:1059–71.
Ristau BT, Tomaszewski JJ, Ost MC. Upper tract urothelial carcinoma: current treatment and outcomes. Urology. 2012;79:749–56.
Colin P, Koenig P, Ouzzane A, et al. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int. 2009;104:1436–40.
Stefanovic V, Polenakovic M, Toncheva D. Urothelial carcinoma associated with Balkan endemic nephropathy. A worldwide disease. Pathol Biol. 2011;59:286–91.
Gray R. A class of K‑sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16(3):1141–54.
Frederick L, Greene DLP, Irvin D. et al. American Joint Committee on Cancer (AJCC) staging manual, 6th ed. Philadelphia: Springer; 2002.
Epstein JI, Amin MB, Reuter VR, et al. The world health organization/international society of urological pathology consensus classification of urothelial neoplasms of the urinary bladder. Bladder consensus conference committee. Am J Surg Pathol. 1998;22:1435–48.
Shariat SF, Favaretto RL, Gupta A, et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2011;29:481–6.
Fernandez MI, Shariat SF, Margulis V, et al. Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. Urology. 2009;73:142–6.
Choo MS, Jeong CW, Kwak C, et al. Effect of sex on prognosis of urothelial carcinoma: propensity score matching analysis. Clin Genitourin Cancer. 2015;13:113–21.
Sikic D, Wach S, Taubert H, et al. Female gender is an age-dependent negative prognostic factor for patients with upper tract Urothelial carcinoma. Anticancer Res. 2015;35:4277–81.
Liu JY, Li YH, Zhang ZL, et al. Age-Specific effect of gender on upper tract urothelial carcinoma outcomes. Med Oncol. 2013;30:640–6.
Hung PH, Shen CH, Tsai HB, et al. Gender effect on renal outcome in patients with urothelial carcinoma. World J Urol. 2011;29:511–6.
Lughezzani G, Sun M, Perrotte P, et al. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance Epidemiology, and End Results database. Urology. 2010;75:321–7.
Waldhoer T, Berger I, Haidinger G, et al. Sex differences of ≥ pT1 bladder cancer survival in Austria: a descriptive, long-term, nation-wide analysis based on 27,773 patients. Urol Int. 2015;94:383–9.
Henning A, Wehrberger C, Madersbacher S, et al. Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int. 2013;112:68–73.